UnknownNCT05894902
Study of Oral SM-001 in Healthy Adults
This study has an unknown status in the United States. It is testing SM-001 for PTSD.
In SeattlePTSD, DepressionDrugA study involving a medication or substance.From 25 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
UnknownNCT00583193
Duloxetine Monotherapy in the Treatment of PTSD
This study has an unknown status in the United States. It focuses on PTSD.
In AlbuquerquePTSDDrugOver 18 Years
CompletedNCT01338818
Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder
This study is completed in the United States, in Belgium, in Colombia, .... It focuses on ADHD.
Multiple locations, including Little RockADHDDrugFrom 18 Years to 60 Years
CompletedEUCTR 2020-004291-18
Long-Term Extension Study for people with Treatment-Resistant Major Depressive Disorder Who are Continuing Esketamine Nasal Spray Treatment From Study 54135419TRD3013
This study is completed in Belgium, in Germany, in Czechia, .... It focuses on depression.
In GermanyDepressionOther
CompletedNCT04143217
Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including Beverly HillsADHDDrugFrom 18 Years to 65 Years
CompletedNCT02050854
Safety study of pharmacokinetics of Aripiprazole in schizophrenia
This study is completed in the United States. It is testing pharmacokinetics of Aripiprazole for schizophrenia.
Multiple locations, including Garden GroveBipolarity, SchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT06235905
Of SPN-820 in Adults With Major Depressive Disorder
This study is completed in the United States. It focuses on depression.
In TemeculaDepressionDrugFrom 18 Years to 65 Years
OngoingEUCTR 2008-000453-35
Phase IIa study exploring safety and potential efficacy of recombinant human erythropoietin in early mild Alzheimer Dementia and therapy-refractory Major Depression (“EPO-AD”)
This study is ongoing in Germany. It focuses on depression.
In GermanyDepressionOther
CompletedNCT00586573
Study of Namenda in Adult Subjects With ADHD and ADHD NOS
This study is completed in the United States. It is testing namenda for ADHD.
In CambridgeADHDDrugFrom 18 Years to 55 Years
CompletedNCT06126185
Study Synbiotic Treatment for Autism Spectrum Disorder
This study is completed in China. It focuses on Anxiety.
In Hong KongAnxietyOtherFrom 2 Years to 12 Years
CompletedNCT06185985
Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms
This study is completed in the United States. It focuses on ADHD.
In New YorkADHDDrugOver 18 Years
CompletedNCT02160262
Safety Study in Adults With ADHD
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including Beverly HillsADHDDrugFrom 18 Years to 55 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.